‘The world’s most expensive medical test’

The World Health Organization (WHO) has revealed the price tag of the most expensive cancer diagnostic test in the world, the Radiology Regional Information System (RIRIS).

It is expected to cost the world $1.4 trillion (USD) to implement, according to the WHO.

The new system, which is based on an algorithm developed by the company AstraZeneca, will be implemented over the next three years, the WHO said.

The system will be deployed in nearly half of the world’s countries.

The RIRIS system uses a system called RADICON to determine the type of cancer and the specific location of the tumor.

If a diagnosis is made, the system will then give an algorithm that identifies the most appropriate treatment, according the WHO’s statement.

The RIRis system is based in France and was first introduced in the United States in 2005.

The company says the system has been used in more than 600,000 patients across more than 1,300 countries and in about 100,000 tests since its introduction in the US in 2008.

The U.S. will have a phased rollout, with the first tests being administered to patients in 2019.RIRis has been on the market since 2006 and has become a standard method of detecting cancer in the U.K. and the Netherlands.

The WHO said the system was designed to be used by both patients and health care professionals.

The WHO said in its announcement that its goal is to use RIRs to treat patients and improve patient outcomes, especially among the poorer, sicker populations.

The system, it said, will allow hospitals to collect and analyze data to better inform their response to patients, and to reduce health disparities in healthcare.

The data can then be used to improve care, the organization said.

The global cost of the system, according a WHO analysis, will total about $1,865,000 (USD).

The WHO added that in the first year of its rollout, there will be 2,000 new tests being offered.